Treatment of microvascular angina: the need for precision medicine

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

(2015) C. Noel Bairey Merz et al.   EUROPEAN HEART JOURNAL

Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries

(2014) Peter Ong et al.   CIRCULATION

Effects of Ranolazine on Noninvasive Coronary Flow Reserve in Patients with Myocardial Ischemia But without Obstructive Coronary Artery Disease

(2014) Ercole Tagliamonte et al.   ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Effects of Ivabradine and Ranolazine in Patients With Microvascular Angina Pectoris

(2013) Angelo Villano et al.   AMERICAN JOURNAL OF CARDIOLOGY

Management of Microvascular Angina Pectoris

(2013) Gaetano A. Lanza et al.   American Journal of Cardiovascular Drugs

Methods to investigate coronary microvascular function in clinical practice

(2012) Gaetano A. Lanza et al.   Journal of Cardiovascular Medicine

Ranolazine Improves Angina in Women With Evidence of Myocardial Ischemia But No Obstructive Coronary Artery Disease

(2011) Puja K. Mehta et al.   JACC-Cardiovascular Imaging

Primary Coronary Microvascular Dysfunction

(2010) Gaetano Antonio Lanza et al.   CIRCULATION

Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X

(2010) Alfonso Sestito et al.   Journal of Cardiovascular Medicine

Low Diagnostic Yield of Elective Coronary Angiography

(2010) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term prognosis of patients with cardiac syndrome X

(2008) Priscilla Lamendola et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Ranolazine for chronic stable angina

(2008) David T Nash et al.   LANCET